- Home
- KYMR vs SUZ Comparison
KYMR vs SUZ Comparison
Compare KYMR & SUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYMR | SUZ |
|---|---|---|
| Founded | 2015 | 1924 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 10.8B |
| IPO Year | 2020 | 2002 |
Fundamental Metrics
Financial Performance| Metric | KYMR | SUZ |
|---|---|---|
| Price | $122.17 | $8.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 24 | 6 |
| Target Price | ★ $139.83 | $12.38 |
| AVG Volume (30 Days) | 745.8K | ★ 3.0M |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 2.17% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,211,000.00 | N/A |
| Revenue This Year | $167.19 | $8.90 |
| Revenue Next Year | N/A | $15.03 |
| P/E Ratio | ★ N/A | $5.58 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $55.66 | $7.56 |
| 52 Week High | $130.05 | $11.54 |
Technical Indicators
Market Signals| Indicator | KYMR | SUZ |
|---|---|---|
| Relative Strength Index (RSI) | 64.76 | 63.87 |
| Support Level | $110.64 | $8.09 |
| Resistance Level | $128.95 | $9.17 |
| Average True Range (ATR) | 5.03 | 0.21 |
| MACD | 1.50 | 0.07 |
| Stochastic Oscillator | 96.51 | 93.20 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
About SUZ Suzano S.A.
Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.